United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A bought 1,500 and sold 8,000 United Therapeutics Corporation shares (Form 4)

Traded May 26, 2026 · Filed May 27, 2026

On May 26, 2026, Rothblatt Martine A (Director, Chairperson & CEO) bought 1,500 and sold 8,000 United Therapeutics Corporation shares under a trading plan, leaving 40,513 shares. Filed May 27, 2026 (Form 4).

Bought
1,500 shares (US$864K at US$575.96)
Sold
8,000 shares (US$4.58M at an average US$572.37)
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 26, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 26, 2026Common StockSale45US$560.5249,968Direct
May 26, 2026Common StockSale35US$560.7449,933Direct
May 26, 2026Common StockSale40US$562.1749,893Direct
May 26, 2026Common StockSale240US$564.0249,653Direct
May 26, 2026Common StockSale320US$566.3649,333Direct
May 26, 2026Common StockSale520US$567.4248,813Direct
May 26, 2026Common StockSale958US$568.6347,855Direct
May 26, 2026Common StockSale642US$569.6947,213Direct
May 26, 2026Common StockSale683US$570.8446,530Direct
May 26, 2026Common StockSale717US$571.7745,813Direct
May 26, 2026Common StockSale600US$572.6645,213Direct
May 26, 2026Common StockSale560US$574.5744,653Direct
May 26, 2026Common StockBuy1,500US$575.9643,153Direct
May 26, 2026Common StockSale1,620US$577.0341,533Direct
May 26, 2026Common StockSale1,020US$577.9740,513Direct

Source

View original at SEC

Related